title: Stanozolol-induced bland cholestasis.
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain.
authors.forename: Javier
authors.initials: J
authors.lastname: Ampuero
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain.
authors.forename: Emilio Suárez
authors.initials: ES
authors.lastname: García
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain.
authors.forename: Marina Millán
authors.initials: MM
authors.lastname: Lorenzo
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain.
authors.forename: Raquel
authors.initials: R
authors.lastname: Calle
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain.
authors.forename: Paula
authors.initials: P
authors.lastname: Ferrero
authors.affiliation: Unit for Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, University of Sevilla, Sevilla, Spain. Electronic address: mromerogomez@us.es.
authors.forename: Manuel Romero
authors.initials: MR
authors.lastname: Gómez
mesh_terms: D000328:Adult; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced*; D004044:Dietary Proteins; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D058573:Performance-Enhancing Substances / Q000008:administration & dosage / Q000009:adverse effects*; D011537:Pruritus / Q000139:chemically induced; D012646:Self Administration; D012651:Self Medication; D012907:Smoking / Q000009:adverse effects; D013197:Stanozolol / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D045930:Anabolic Agents; D004044:Dietary Proteins; D058573:Performance-Enhancing Substances; D013197:Stanozolol